Valuation: Enovis Corporation

Market Cap 148.22Cr 129.86Cr 119.74Cr 110.64Cr 209.78Cr 14TCr 213.27Cr 1.43TCr 561.04Cr 6.96TCr 556.48Cr 544.4Cr 24TCr P/E 2026 *
212x
P/E 2027 * 26.7x
Enterprise Value 267.96Cr 234.76Cr 216.46Cr 200.01Cr 379.24Cr 26TCr 385.55Cr 2.59TCr 1.01TCr 13TCr 1.01TCr 984.16Cr 43TCr EV / Sales 2026 *
1.14x
EV / Sales 2027 * 1.03x
Free-Float
98.38%
Yield 2026 *
-
Yield 2027 * -
1 day+2.10%
1 week+14.44%
Current month+24.40%
1 month+17.21%
3 months+5.45%
6 months-13.24%
Current year-3.34%
1 week 22.93
Extreme 22.93
26.5
1 month 19.14
Extreme 19.14
26.5
Current year 19.14
Extreme 19.14
29.89
1 year 19.14
Extreme 19.14
34.28
3 years 19.14
Extreme 19.14
66.14
5 years 19.14
Extreme 19.14
164.01
10 years 19.14
Extreme 19.14
164.01
Manager TitleAgeSince
Chief Executive Officer 61 12/05/2025
Director of Finance/CFO 47 01/01/2023
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 55 13/05/2008
Director/Board Member 67 21/09/2010
Chairman 64 21/05/2025
Date Insider Type Main position Quantity % Market Cap.
30/06Free

Director

846 0.0015%
15/06Buy

Chief Administrative Officer

1,000 0.0017%
11/06Free

Chief Administrative Officer

1,000 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
+2.10%+14.44%-28.35%-60.00% 148.22Cr
+0.82%+0.99%-16.46%+11.68% 13TCr
+0.84%+1.15%-1.34%-2.61% 1.29TCr
-1.52%+2.95%+43.33%+115.86% 896.56Cr
+4.14%-2.38%-47.99%-72.05% 397.65Cr
-0.47%-1.34%+22.30%+45.04% 269.84Cr
+0.61%-7.70%-14.72%-20.20% 174.47Cr
+0.49%-3.87%-4.88%-25.01% 160.52Cr
+0.47%+10.24%-62.83%-83.35% 149.14Cr
Average +0.83%+1.73%-12.33%-10.07% 1.79TCr
Weighted average by Cap. +0.75%+1.13%-12.46%+12.57%

Financials

2026 *2027 *
Net sales 234.49Cr 205.44Cr 189.42Cr 175.03Cr 331.88Cr 22TCr 337.4Cr 2.26TCr 887.58Cr 11TCr 880.36Cr 861.25Cr 38TCr 246.63Cr 216.08Cr 199.23Cr 184.1Cr 349.06Cr 24TCr 354.87Cr 2.38TCr 933.53Cr 12TCr 925.94Cr 905.83Cr 40TCr
Net income 29.6L 25.93L 23.91L 22.09L 41.89L 28Cr 42.59L 2.86Cr 1.12Cr 14Cr 1.11Cr 1.09Cr 48Cr 5.42Cr 4.75Cr 4.38Cr 4.05Cr 7.67Cr 517.1Cr 7.8Cr 52Cr 21Cr 254.71Cr 20Cr 20Cr 876.59Cr
Net Debt 119.73Cr 104.9Cr 97Cr 89Cr 169.46Cr 11TCr 172.28Cr 1.16TCr 453.21Cr 5.62TCr 449.52Cr 439.76Cr 19TCr 106.59Cr 93Cr 86Cr 80Cr 150.86Cr 10TCr 153.37Cr 1.03TCr 403.46Cr 5.01TCr 400.18Cr 391.49Cr 17TCr
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
10/26/10 $25.75 +2.10% 7,68,242
09/26/09 $25.22 +6.73% 19,40,894
08/26/08 $23.63 -7.41% 12,13,833
07/26/07 $25.52 -1.47% 9,89,227
06/26/06 $25.90 +15.11% 21,55,004
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
25.75USD
Average target price
40.73USD
Spread / Average Target
+58.16%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock